ACADIA Pharmaceuticals Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	268.1M	284.0M	278.6M	264.6M	244.3M	259.6M	250.4M	242.0M
Cost of Goods Sold	24.8M	26.2M	21.6M	20.7M	20.4M	21.8M	18.9M	18.2M
Gross Profit	243.3M	257.8M	257.0M	243.8M	223.9M	237.8M	231.5M	223.7M
R&D Expenses	76.9M	84.8M	87.8M	78.0M	78.3M	100.7M	66.6M	76.2M
Operating Expenses	247.9M	240.4M	221.2M	211.5M	204.6M	84.3M	199.9M	193.3M
Operating Income	-4.6M	17.4M	35.8M	32.4M	19.3M	153.5M	31.6M	30.4M
Other Income / Gains	8.6M	8.9M	8.8M	7.8M	8.5M	7.6M	7.2M	6.7M
Net Income	3.6M	273.6M	71.8M	26.7M	19.0M	143.7M	32.8M	33.4M
EPS (Diluted)	0.02	1.62	0.43	0.16	0.11	0.87	0.20	0.20
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.908	0.908	0.922	0.922	0.917	0.916	0.925	0.925
General And Administrative Expenses	0	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0	0
Selling General And Administrative Expenses	171.0M	155.6M	133.4M	133.5M	126.4M	130.1M	133.3M	117.1M
Other Expenses	0	0	0	0	0	-146.5M	0	0
Cost And Expenses	272.7M	266.6M	242.9M	232.2M	225.0M	106.1M	218.8M	211.5M
Interest Income	0	8.3M	8.2M	7.2M	7.9M	7.0M	6.6M	6.4M
Interest Expense	0	0	0	0	0	0	0	0
Depreciation And Amortization	0	0	3.0M	2.9M	3.0M	5.2M	0	2.6M
Ebitda	-4.6M	26.3M	47.5M	35.3M	22.2M	12.2M	31.6M	33.0M
Ebitdaratio	-0.017	0.093	0.171	0.133	0.091	0.047	0.126	0.136
Operating Income Ratio	-0.017	0.061	0.128	0.122	0.079	0.591	0.126	0.126
Income Before Tax	4.0M	26.3M	44.6M	40.2M	27.8M	161.1M	38.8M	37.2M
Income Before Tax Ratio	0.015	0.093	0.16	0.152	0.114	0.621	0.155	0.154
Income Tax Expense	344K	-247.2M	-27.2M	13.5M	8.8M	17.3M	6.0M	3.8M
Net Income Ratio	0.014	0.963	0.258	0.101	0.078	0.554	0.131	0.138
Epsdiluted	0.02	1.60	0.42	0.16	0.11	0.86	0.20	0.20
Weighted Average Shs Out	170.5M	169.3M	168.8M	167.8M	166.8M	166.5M	166.0M	165.6M
Weighted Average Shs Out Dil	172.7M	171.4M	170.7M	168.7M	167.7M	166.4M	166.2M	166.2M